Showing 1 - 2 results of 2 for search 'Mark Millard, MD', query time: 0.01s
Refine Results
-
1
Omalizumab is ineffective in regulating proasthmatic serum cytokine and chemokine levels in nonresponders with high BMI by Agnes Yang, BS, Chao Gu, PhD, Katherine Upchurch, PhD, Adrien Caffiers, MS, Mark Millard, MD, Laurie Baert, PhD, HyeMee Joo, PhD, SangKon Oh, PhD
Published 2025-05-01Get full text
Article -
2